Pre-operative Assessment of Muscle Mass to Predict Surgical Complications and Prognosis in Patients With Endometrial Cancer

Annals of Surgical Oncology

Volumn 22, Issue 3, 2015, Pages 972-979

  Kuroki, L M ^a   Mangano, M ^b   Allsworth, J E ^c   Menias, C O ^d   Massad, L S ^a   Powell, M A ^a   Mutch, D G ^a   Thaker, P H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOMETRIUM CANCER; FEMALE; HISTOLOGY; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPOTHESIS; HYSTERECTOMY; IMAGE ANALYSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MIDDLE AGED; MORBIDITY; MUSCLE MASS; NATIONAL HEALTH ORGANIZATION; OBESITY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PSOAS MUSCLE; RACE DIFFERENCE; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SARCOPENIA; SURVIVAL RATE; ADENOCARCINOMA, CLEAR CELL; CANCER GRADING; CANCER STAGING; CARCINOMA, PAPILLARY; CLINICAL TRIAL; COMORBIDITY; COMPLICATION; CYSTADENOCARCINOMA, SEROUS; DIAGNOSIS; ENDOMETRIAL NEOPLASMS; ETIOLOGY; FOLLOW UP; LENGTH OF STAY; MALE; MORTALITY; MUSCLE STRENGTH; PATHOLOGY; PHYSIOLOGY; PREOPERATIVE CARE; PROGNOSIS; RISK FACTOR; SKELETAL MUSCLE; TUMOR RECURRENCE;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; BODY MASS INDEX; CARCINOMA, PAPILLARY; COMORBIDITY; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBESITY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA; SURVIVAL RATE;

EID: 84924956300     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-4040-8     Document Type: Article

References (27)

1. Studley HO. Percentage of weight loss: a basic indicator of surgical risk in patients with chronic peptic ulcer. JAMA. 1936;106:458–60.
2. Raslan M, Gonzalez MC, Torrinhas RS, et al. Complementarity of Subjective Global Assessment (SGA) and Nutritional Risk Screening 2002 (NRS 2002) for predicting poor clinical outcomes in hospitalized patients. Clin Nutr. 2011;30:49–53.
3. Awad S, Lobo DN. What’s new in perioperative nutritional support?. Curr Opin Anaesthesiol. 2011;24:339–48.
4. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137:231–43.
5. Baumgartner RN, Wayne SJ, Waters DL, et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004;12:1995–2004.
6. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–63.
7. Pichard C, Kyle UG, Morabia A, et al. Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr. 2004;79:613–8.
8. Kyle UG, Pirlich M, Lochs H, Schuetz T, Pichard C. Increased length of hospital stay in underweight and overweight patients at hospital admission: a controlled population study. Clin Nutr. 2005;24:133–42.
9. Cosqueric G, Sebag A, Ducolombier C, et al. Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr. 2006;96:895–901.
10. Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166–73, 173 e161.
11. Garth AK, Newsome CM, Simmance N, Crowe TC. Nutritional status, nutrition practices, and postoperative complications in patients with gastrointestinal cancer. J Hum Nutr Diet. 2010;23(4):393–401.
12. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15:6973–9.
13. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.
14. Kanda M, Fujii T, Kodera Y, et al. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98:268–74.
15. Pacelli F, Bossola M, Rosa F, et al. Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery? Clin Nutr. 2008;27:398–407.
16. Sabel MS, Lee J, Cai S, et al. Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol. 2011;18:3579–85.
17. Skipworth J, Foster J, Raptis D, Hughes F. The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma. Dis Esophagus. 2009;22:559–63.
18. Windsor JA, Hill GL. Weight loss with physiologic impairment: a basic indicator of surgical risk. Ann Surg. 1988;207:290–6.
19. Schwegler I, von Holzen A, Gutzwiller JP, et al. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg. 97:92–7.
20. Prado CM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15:2920–6.
21. Mourtzakis M, Prado CM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997–1006.
22. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. 1998;85:115–22.
23. Awad S, Tan BH, Cui H, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr. 2012;31:74–7.
24. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr. 2012;31:583–601.
25. Bilbao C, Rodriguez G, Ramirez R, et al. The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer. Int J Cancer. 2006;119:563–70.
26. Lax SF, Kendall B, Tashiro H, Slebos RJ, Hedrick L. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer. 2000;88:814–24.
27. Risinger JI, Hayes K, Maxwell GL, et al. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res. 1998;4:3005–10.